CIM Stock Analysis: Chimera Investment | NYSE
REIT - Mortgage | NYSE, USA | Market Cap: 733m USD | 12M Return: -24.8% | US16934Q8024 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 15.2M
EPS Trend: 81.1%
Qual. Beats: -1
Rev. Trend: 88.9%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Chimera Investment Corporation (CIM) is a U.S.-based mortgage REIT that operates through two segments: Investment Portfolio and Residential Origination. The company invests in, originates, and manages a range of mortgage assets, including residential mortgage loans, agency and non-agency mortgage-backed securities, business purpose loans, investor loans, mortgage servicing rights, and other real estate-related assets. It also holds investment-grade, non-investment-grade, and non-rated securities, and provides third-party advisory services.
As a REIT, Chimera is required to distribute at least 90% of its taxable income to shareholders as dividends, which is a defining feature of the structure and a key driver of investor returns. Mortgage REITs like Chimera typically generate income from the net interest spread between the yield on their mortgage assets and their cost of funding, making them highly sensitive to interest rate movements. Founded in 2007 and headquartered in New York, the company has a small-cap market presence within the Financials sector.
- Fed rate cuts compress net interest spreads
- Residential origination segment revenue scales higher
- Book value pressured by widening RMBS credit spreads
| Net Income: 1.21m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.01 > 0.02 and ΔFCF/TA -1.70 > 1.0 |
| NWC/Revenue: -1.05k% < 20% (prev 1.34k%; Δ -2.40k% < -1%) |
| CFO/TA -0.01 > 3% & CFO -142.8m > Net Income 1.21m |
| Net Debt (13.0b) to EBITDA (169.4m): 76.80 < 3 |
| Current Ratio: 0.07 > 1.5 & < 3 |
| Outstanding Shares: last quarter (83.8m) vs 12m ago 1.47% < -2% |
| Gross Margin: 52.06% > 18% (prev 64.48%; Δ -12.42% > 0.5%) |
| Asset Turnover: 4.38% > 50% (prev 2.80%; Δ 1.57% > 0%) |
| Interest Coverage Ratio: 0.25 > 6 (EBIT TTM 150.3m / Interest Expense TTM 593.6m) |
| A: -0.44 (Total Current Assets 555.9m - Total Current Liabilities 7.69b) / Total Assets 16.0b |
| B: 0.28 (Retained Earnings 4.55b / Total Assets 16.0b) |
| C: 0.01 (EBIT TTM 150.3m / Avg Total Assets 15.5b) |
| D: 0.18 (Book Value of Equity 2.42b / Total Liabilities 13.6b) |
| Altman-Z'' = -1.74 = D |
As of October 15, 2026, the stock is trading at USD 8.48 with a total of 2,023,116 shares traded. Over the past week, the price has changed by -5.36%, over one month by -19.93%, over three months by -31.97% and over the past year by -24.77%.
Current recommended Stop Loss: 8.10 (which is 4.5% or 1.4 ATR below the current price).
Chimera Investment has received a consensus analysts rating of 3.40. Therefore, it is recommended to hold CIM.
- StrongBuy: 1
- Buy: 0
- Hold: 4
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 14.2 | 67.1% |
P/E Forward = 5.2854
P/S = 3.3301
P/B = 0.3865
P/EG = 3.3319
Revenue TTM = 676.4m USD
EBIT TTM = 150.3m USD
EBITDA TTM = 169.4m USD
Long Term Debt = 13.5b USD (from longTermDebt, last quarter)
Short Term Debt = 6.03b USD (from shortTermDebt, last fiscal year)
Debt = 13.5b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 13.0b USD (calculated: Debt 13.5b - CCE 444.0m)
Enterprise Value = 13.7b USD (732.7m + Debt 13.5b - CCE 444.0m)
Interest Coverage Ratio = 0.25 (Ebit TTM 150.3m / Interest Expense TTM 593.6m)
EV/FCF = -96.19x (Enterprise Value 13.7b / FCF TTM -142.8m)
FCF Yield = -1.04% (FCF TTM -142.8m / Enterprise Value 13.7b)
FCF Margin = -21.12% (FCF TTM -142.8m / Revenue TTM 676.4m)
Net Margin = 0.18% (Net Income TTM 1.21m / Revenue TTM 676.4m)
Gross Margin = 52.06% ((Revenue TTM 676.4m - Cost of Revenue TTM 324.3m) / Revenue TTM)
Gross Margin QoQ = 84.30% (prev 22.00%)
Tobins Q-Ratio = 0.86 (Enterprise Value 13.7b / Total Assets 16.0b)
Interest Expense / Debt = 4.41% (Interest Expense 593.6m / Debt 13.5b)
Taxrate = 0.97% (2.27m / 232.8m)
NOPAT = 148.9m (EBIT 150.3m * (1 - 0.97%))
Current Ratio = 0.07 (Total Current Assets 555.9m / Total Current Liabilities 7.69b)
Debt / Equity = 5.57 (Debt 13.5b / totalStockholderEquity, last quarter 2.42b)
Debt / EBITDA = 76.80 (Net Debt 13.0b / EBITDA 169.4m)
Debt / FCF = -91.06 (negative FCF - burning cash) (Net Debt 13.0b / FCF TTM -142.8m)
Total Stockholder Equity = 2.51b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.01% (Net Income 1.21m / Total Assets 16.0b)
RoE = 0.05% (Net Income TTM 1.21m / Total Stockholder Equity 2.51b)
RoCE = 0.94% (EBIT 150.3m / Capital Employed (Equity 2.51b + L.T.Debt 13.5b))
RoIC = 0.68% (NOPAT 148.9m / Invested Capital 21.9b)
WACC = 4.58% (E(732.7m)/V(14.2b) * Re(8.36%) + D(13.5b)/V(14.2b) * Rd(4.41%) * (1-Tc(0.01)))
Discount Rate = 8.36% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 73.89 | Cagr: 1.13%
[DCF] Fair Price = unknown (Cash Flow -142.8m)
EPS Correlation: 81.09 | EPS CAGR: 8.49% | SUE: -1.41 | # QB: -1
Revenue Correlation: 88.85 | Revenue CAGR: 51.41% | SUE: 0.11 | # QB: 0
EPS current Quarter (2026-09-30): EPS=0.47 | Chg30d=+0.73% | Revisions=-50% | Analysts=3
EPS current Year (2026-12-31): EPS=1.92 | Chg30d=-0.17% | Revisions=-50% | GrowthEPS=+14.3% | GrowthRev=+11.5%
EPS next Year (2027-12-31): EPS=2.08 | Chg30d=-0.60% | Revisions=-50% | GrowthEPS=+8.1% | GrowthRev=+0.4%
[Analyst] Revisions Ratio: -75% (up=0, down=9)